Medicare Enrolled
Dr. Mhd Iyad Alshwaf, MD
Rheumatology · Lansing, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alshwaf from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alshwaf?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alshwaf
Dr. Mhd Iyad Alshwaf is a rheumatology specialist in Lansing, MI, with 8 years of NPI registration. Based on federal Medicare data, Dr. Alshwaf performed 86,982 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Alshwaf received a total of $19,785 from 41 pharmaceutical and/or device companies across 1255 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alshwaf is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 8 years of NPI registration
▲ Top 5% volume in MI
$19,785 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗86,982
Medicare services
Top 5% in MI for rheumatology
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 26,240 | $5 | $8 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
23,100 | $10 | $40 |
| Romosozumab injection (Evenity) for osteoporosis | 15,120 | $8 | $15 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
8,250 | $32 | $66 |
| Denosumab injection (Prolia/Xgeva) | 6,900 | $18 | $36 |
| Belimumab injection, 10 mg An injection of belimumab, a medication administered at a dose of 10 mg. |
3,432 | $38 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
846 | $87 | $175 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
563 | $61 | $135 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
456 | $1 | $7 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
431 | $10 | $65 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
284 | $45 | $190 |
| Anti-nausea injection (ondansetron/Zofran) | 272 | $0 | $4 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
165 | $12 | $95 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
140 | $20 | $120 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
126 | $9 | $30 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
121 | $92 | $270 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
120 | $4 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
111 | $8 | $20 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
60 | $0 | $10 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
60 | $6 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $109 | $270 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
36 | $1 | $20 |
| New patient office visit, complex (60-74 min) | 33 | $140 | $320 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
21 | $57 | $199 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
21 | $29 | $50 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
18 | $76 | $80 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
11 | $121 | $230 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
36.5% high complexity
61.6% medium
1.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,785
Total received (2018-2024)
Avg $2,826/year across 7 years
Top 17% in MI for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
1,255
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,823
2023
$4,342
2022
$3,875
2021
$2,675
2020
$1,639
2019
$2,875
2018
$556
Payments by company (2024)
Amgen Inc.
$731
Janssen Biotech, Inc.
$712
ABBVIE INC.
$616
AstraZeneca Pharmaceuticals LP
$244
UCB, Inc.
$234
ANI Pharmaceuticals, Inc.
$214
Novartis Pharmaceuticals Corporation
$200
Boehringer Ingelheim Pharmaceuticals, Inc.
$135
United Therapeutics Corporation
$115
Mallinckrodt Hospital Products Inc.
$112
Organon Llc
$110
Lilly USA, LLC
$45
Alexion Pharmaceuticals, Inc.
$43
SOBI, INC
$43
PFIZER INC.
$41
Sandoz Inc.
$34
Fresenius Kabi USA, LLC
$31
Alvogen Inc
$30
Radius Health, Inc.
$29
Merck Sharp & Dohme LLC
$26
TerSera Therapeutics LLC
$22
E.R. Squibb & Sons, L.L.C.
$19
GENZYME CORPORATION
$19
Genentech USA, Inc.
$18
Top 3 companies account for 53.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$4,545
Amgen Inc.
$3,182
UCB, Inc.
$1,327
E.R. Squibb & Sons, L.L.C.
$1,134
ABBVIE INC.
$1,098
Novartis Pharmaceuticals Corporation
$1,046
AbbVie Inc.
$1,044
PFIZER INC.
$679
AstraZeneca Pharmaceuticals LP
$642
Boehringer Ingelheim Pharmaceuticals, Inc.
$594
Genentech USA, Inc.
$484
Lilly USA, LLC
$465
GlaxoSmithKline, LLC.
$412
Aurinia Pharma U.S., Inc.
$329
Regeneron Healthcare Solutions, Inc.
$309
Horizon Therapeutics plc
$306
ANI Pharmaceuticals, Inc.
$294
AbbVie, Inc.
$279
United Therapeutics Corporation
$229
Mallinckrodt Hospital Products Inc.
$224
Alexion Pharmaceuticals, Inc.
$164
Organon LLC
$114
Organon Llc
$110
Radius Health, Inc.
$96
Mallinckrodt Enterprises LLC
$79
Actelion Pharmaceuticals US, Inc.
$69
GENZYME CORPORATION
$63
Sandoz Inc.
$56
Janssen Scientific Affairs, LLC
$54
Daiichi Sankyo Inc.
$53
Merck Sharp & Dohme LLC
$49
Alvogen Inc
$48
Fresenius Kabi USA, LLC
$46
SOBI, INC
$43
Bioventus LLC
$27
Boston Scientific Corporation
$25
TerSera Therapeutics LLC
$22
Exeltis, USA Inc.
$16
Sobi, Inc
$13
Alnylam Pharmaceuticals Inc.
$13
Pfizer Inc.
$3
Top 3 companies account for 45.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · Bimzelx · CAPVAXIVE · COSENTYX · CYLTEZO · Cimzia · EVENITY · Enbrel · GELSYN 3 · GELSYN-3 · HADLIMA · HUMIRA · HYRIMOZ · Humira · ILARIS · INFLECTRA · INJECTAFER · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · LUPKYNIS · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · Otezla · PNEUMOVAX 23 · POMPE - DISEASE · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · SOLIRIS · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · UPTRAVI · Ultomiris · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
8
County median income
$64,354
Nearest hospital to ZIP centroid (approximate)
MCLAREN GREATER LANSING
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alshwaf is a mixed practice specialist, with above-average Medicare volume (top 5% in MI).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alshwaf experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Alshwaf performed 26,240 tocilizumab injection (actemra) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Alshwaf receive payments from pharmaceutical companies?
Yes. Dr. Alshwaf received a total of $19,785 from 41 companies across 1,255 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alshwaf's costs compare to other rheumatologists in Lansing?
Dr. Alshwaf's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alshwaf) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Lansing
Browse rheumatologists in Lansing ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in MI
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in MI
Which MI rheumatologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology